Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience.
Hultcrantz M, Derkach A, Hassoun H, Korde N, Maclachlan K, Mailankody S, Patel D, Shah UA, Tan CR, Chung DJ, Lahoud OB, Landau HJ, Scordo M, Shah GL, Nemirovsky D, Firestone RS, Akhlaghi T, Shekarkhand T, Giralt SA, Lesokhin AM, Usmani SZ.
Hultcrantz M, et al. Among authors: tan cr.
Blood Neoplasia. 2025 Apr 16;2(3):100103. doi: 10.1016/j.bneo.2025.100103. eCollection 2025 Aug.
Blood Neoplasia. 2025.
PMID: 40575079
Free PMC article.